Herpes - Sanofi-aventis Announces First Half of 2006: Sales growth of 7.7%
Sanofi-aventis Announces First Half of 2006: Sales growth of 7.7% PR Newswire (press release), NY - 6 hours ago Zostavax(R), a vaccine against herpes zoster (shingles) and herpes zoster related sanofi-aventis the rights to develop and market an oral anticancer agent, S-1 'Forgotten HPV' Revealed PR Newswire (press release), NY - Jul 27, 2006 HPV -- Almost half confuse genital warts with herpes - 48 percent believe herpes is another in the mouth or throat of a person who has had oral sexual contact WTC: Surgeons Describe Face-Saving Transplant MedPage Today, NJ - Jul 27, 2006 The surgeons also performed mucosal repair of the oral and nasal vestibules, bilateral six months, one month after having an infection with human herpes virus 1 A race against time Africa Today, UK - Jul 31, 2006 one suffers persistent cough for up to one month, chronic herpes simplex, generalised itching-dermatitis, and generalised lymph node swelling and oral thrush. FDA Approves Novartis's (NVS) FAMVIR Tablet StreetInsider.com (subscription), MI - Jul 28, 2006 also approved Famvir as a single-dose treatment for recurrent herpes labialis (cold Data shows that when patients were treated with the oral antiviral Famvir
<< Home